• 

EMBO welcomes 65 new members

 

Heidelberg, 16 June 2017 – EMBO announces today that 65 outstanding life scientists have been elected to its membership, joining a group of more than 1700 of the best researchers in Europe and around the world.

 

The total number includes 56 EMBO Members residing in 19 Member States of the European Molecular Biology Conference (EMBC) and nine EMBO Associate Members currently working in the USA and Japan.

 

“Election to the EMBO Membership is recognition of research excellence, and I am pleased to welcome so many great scientists to our organisation,” says EMBO Director Maria Leptin.

 

She continues: “We received more nominations than ever before during this election cycle, which pays tribute to the strength and diversity of the European life sciences. Drawing on our new members’ expertise and insight will be invaluable in helping EMBO to deliver and strengthen its programmes and activities in the years to come.”

 

EMBO Members are actively involved in the execution of the organisation’s initiatives by evaluating applications for EMBO funding and by serving on EMBO Council, Committees and Editorial Boards.

 

New EMBO Members and Associate Members will be formally welcomed at the EMBO Members’ Meeting in Heidelberg 18-20 October 2017.

 

An online directory with all existing and new EMBO Members is available at people.embo.org.

 

Selected statistics about this year’s intake

• 40% women
• Average age of newly elected members: 50.8 years
• Newly elected members reside in 21 countries

 

New EMBO Members 2017

Ido Amit	Weizmann Institute of Science, Rehovot, IL
Alberto Bardelli	University of Turin, IT
Ralf Bartenschlager	University of Heidelberg & DKFZ Heidelberg, DE
Renata Basto	Institut Curie, Paris, FR
Eva Benkova	Institute of Science and Technology Austria (IST), Klosterneuburg, AT
Frédéric Berger	Gregor Mendel Institute of Molecular Plant Biology, Vienna, AT
Frances M. Brodsky	University College London, UK
Damian Brunner	University of Zurich, CH
Lena Claesson-Welsh	Uppsala University, SE
Monica M.G. Di Luca	University of Milan, IT
Paula Duque	Instituto Gulbenkian de Ciência, Oeiras, PT
Michael L. Dustin	University of Oxford, UK
Eran Elinav	Weizmann Institute of Science, Rehovot, IL
Jeremy Farrar	Wellcome Trust, London, UK
Martin Fussenegger	ETH Zurich, Basel, CH
Fátima Gebauer Hernández	Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, ES
Niko Geldner	University of Lausanne, CH
Daniel W. Gerlich	Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, AT
Isabel Gordo	Instituto Gulbenkian de Ciência, Oeiras, PT
Stephan Grill	Technical University, Dresden, DE
Anja Groth	Biotech Research and Innovation Centre (BRIC), Copenhagen, DK
Jacob Hanna	Weizmann Institute of Science, Rehovot, IL
Clare Isacke	Institute of Cancer Research, London, UK
Roman Jerala	National Institute of Chemistry, Ljubljana, SI
Johanna Joyce	University of Lausanne, Ludwig Institute for Cancer Research, Lausanne, CH
Roy Kishony	Technion - Israel Institute of Technology, Haifa, IL
Thomas Klausberger	Medical University of Vienna, AT
Saulius Klimašauskas	Vilnius University, LT
Claudia Köhler	Swedish University of Agricultural Sciences, Uppsala, SE
Magda Konarska	Centre of New Technologies, Warsaw University, Warsaw, PL
Marc Lecuit	Institut Pasteur, Paris, FR
Ben Lehner	Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, ES
Sten Linnarsson	Karolinska Institute, Stockholm, SE
Núria López-Bigas	Institute for Research in Biomedicine, Barcelona, ES
Susanne Mandrup	University of Southern Denmark, Odense, DK
Marta Miaczynska	International Institute of Molecular and Cell Biology, Warsaw, PL
Irene Miguel-Aliaga	MRC London Institute of Medical Sciences, Imperial College London, UK
Stefan Mundlos	Max Planck Institute for Molecular Genetics, Berlin, DE
Mary O'Connell	CEITEC, Masaryk University, Brno, CZ
Sarah E. O'Connor	John Innes Centre, Norwich, UK
Csaba Pál	Biological Research Centre, Szeged, HU
Tracy Palmer	University of Dundee, UK
Franck Perez	Institut Curie, Paris, FR
Ramesh S. Pillai	University of Geneva, CH
Panayiota Poirazi	IMBB - FORTH, Heraklion, Crete, GR
Iñaki Ruiz-Trillo	Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Barcelona, ES
Sjors H.W. Scheres	MRC Laboratory of Molecular Biology, Cambridge, UK
Maya Schuldiner	Weizmann Institute of Science, Rehovot, IL
Miguel Soares	Instituto Gulbenkian de Ciência, Oeiras, PT
Charles Swanton	The Francis Crick Institute, London, UK
Elly M. Tanaka	Research Institute of Molecular Pathology (IMP), Vienna, AT
Marc Timmers	University Medical Center Utrecht, NL, & Medical Center, University of Freiburg, DE
Aslıhan Tolun	Boğaziçi University, Istanbul, TR
Alexander van Oudenaarden	Hubrecht Institute, Utrecht, NL
Michael Wagner	University of Vienna, AT
Anton Wutz	ETH Zurich, CH

 

New Associate EMBO Members 2017

Mina J. Bissell	Lawrence Berkeley National Laboratory, Berkeley, US
Piero Carninci	RIKEN Center for Life Science Technologies, Yokohama, JP
Gerard Karsenty	Columbia University, New York, US
Richard E. Lenski	Michigan State University, East Lansing, US
Michael S. Levine	Lewis-Sigler Institute for Integrative Genomics, Princeton University, US
Jennifer Lippincott Schwartz	HHMI Janelia Research Campus, Ashburn, US
Gerald Rubin	HHMI Janelia Research Campus, Ashburn, US
Arthur Weiss	University of California, San Francisco, US
Jonathan Weissman	HHMI and University of California, San Francisco, US